Kenyon is the senior editor of TheBody/TheBodyPro. He has a distinguished track record working in communities impacted by HIV as an activist, writer, and strategist, stretching back long before he joined our team in late 2017. Kenyon's work has been recognized by many institutions, including Out Magazine's "Out 100" and The Advocate's "40 Under 40." He was also named a "Modern Black History Hero" by Black Entertainment Television.
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.
After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.
Four researchers at the HIV Research for Prevention Conference (HIVR4P) presented their work to develop safe and effective anal/vaginal douches and inserts, implantables that are biodegradable, and vaginal rings.
Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.
Alicia Garza talks with TheBodyPRO's Kenyon Farrow about HIV's relative invisibility in black social justice spaces, despite its disproportionate impact on black communities.
Georgia’s Living Bridge Center has found ways to engage rural people living with HIV and retain them in care.
“[The study] shows that the incidence of HIV in this cohort is zero averting 85 new infections," said Jean-Michel Molina, M.D., Ph.D., the lead researcher of the Prévenir study.